Federal Register / Vol. 74, No. 203 / Thursday, October 22, 2009 / Notices 54589 

Place: Doubletree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Lawrence E. Boerboom, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5156, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

8367, boerboom@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 14, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–25405 Filed 10–21–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; ARRA 

AREA Special Emphasis Panel 07. 

Date: November 17, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW., 

Washington, DC 20036. 

Contact Person: Rolf Menzel, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3196, 

MSC 7808, Bethesda, MD 20892, 301–435– 

0952, menzelro@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–OD– 

09–008 BRDG–SPAN and RFA–OD–09–009 

Catalyst ARRA Review Panel 8. 

Date: November 23, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Ross D. Shonat, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5156, 

MSC 7849, Bethesda, MD 20892, 301–435– 

2786, shonatr@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 15, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–25471 Filed 10–21–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Request for Comment: National Center 

for Complementary and Alternative 

Medicine Announcement of Strategic 

Planning Background Papers 

ACTION: Notice. 

SUMMARY: The National Center for 

Complementary and Alternative 

Medicine (NCCAM) is developing its 

third strategic plan and invites the 

public to provide comments on three 

background papers which will support 

the development of this plan. The 

papers will cover three topics: Mission, 

priority setting, and communications 

and decisionmaking. They will be 

publicly available through the NCCAM 

Web site at from on or about October 19 

through November 19, 2009. The public 

is invited to provide comments through 

the NCCAM Web site. 

Background: The National Center for 

Complementary and Alternative 

Medicine (NCCAM) was established in 

1998 with the mission of exploring 

complementary and alternative healing 

practices in the context of rigorous 

science, training CAM researchers, and 

disseminating authoritative information 

to the public and professionals. 

To date, NCCAM’s efforts to 

rigorously study CAM, to train CAM 

researchers, and to communicate with 

the public and professionals, have been 

guided by NCCAM’s previous strategic 

plans, located on the NCCAM Web site 

at http://nccam.nih.gov/about/plans. 

The public is invited to review the 

background papers and provide 

comments from October 15 through 

November 15, 2009. The papers may be 

viewed at http://nccam.nih.gov/. 

Request For Comments: The public is 

invited to provide comments on the 

three background papers that will 

support the development of NCCAM’s 

third strategic plan. Comments may be 

provided through the NCCAM Web site 

at http://nccam.nih.gov. 

For Further Information: To request 

more information, visit the NCCAM 

Web site at http://nccam.nih.gov, call 

1–888–644–6226, or e-mail 

<ncamsp@mail.nih.gov> 

Comments Due Date: Comments 

regarding the draft of NCCAM’s strategic 

plan are best assured of having their full 

effect if received by November 19, 2009. 

Dated: October 13, 2009. 

Jack Killen, 

Deputy Director, National Center for 

Complementary and Alternative Medicine, 

National Institutes of Health. 

[FR Doc. E9–25307 Filed 10–21–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0664] 

Request for Notification From Industry 

Organizations Interested in 

Participating in Selection Process for 

Nonvoting Industry Representatives on 

Public Advisory Committees and 

Request for Nominations for 

Nonvoting Industry Representatives on 

Public Advisory Committees 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is requesting that 

any industry organizations interested in 

participating in the selection of 

nonvoting industry representatives to 

serve on its public advisory committees 

for the Center for Food Safety and 

Applied Nutrition (CFSAN) notify FDA 

in writing. FDA is also requesting 

nominations for nonvoting industry 

representatives to serve on CFSAN’s 

Food Advisory Committee. A nominee 

may either be self-nominated or 

nominated by an organization to serve 

as a nonvoting industry representative. 

Nominations will be accepted for 

current vacancies effective with this 

notice. 

DATES: Any industry organization 

interested in participating in the 

selection of an appropriate nonvoting 

member to represent industry interests 

must send a letter stating that interest to 

FDA by November 23, 2009, for 

vacancies listed in this notice. 

Concurrently, nomination materials for 


dcolon on DSK2BSOYB1PROD with NOTICES